Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28642008

Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2017 Aug
First author
Faivre-Finn C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Aug;18(8):994-995. doi: 10.1016/S1470-2045(17)30439-4.
    note
    Source null
    related pmid
    28642007
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Oct;18(10):e553. doi: 10.1016/S1470-2045(17)30580-6.
    note
    Source null
    related pmid
    28971812
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Oct;18(10):e554. doi: 10.1016/S1470-2045(17)30581-8.
    note
    Source null
    related pmid
    28971813
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2017 Oct;18(10):e555. doi: 10.1016/S1470-2045(17)30620-4.
    note
    Source null
    related pmid
    28971814
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2017 Oct;18(10):e556. doi: 10.1016/S1470-2045(17)30611-3.
    note
    Source null
    related pmid
    28971815
    relationship
    Comment in
  6. citation
    Strahlenther Onkol. 2018 Jan;194(1):73-75. doi: 10.1007/s00066-017-1234-6.
    note
    Source null
    related pmid
    29143097
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2017 Nov;18(11):e627. doi: 10.1016/S1470-2045(17)30808-2.
    note
    Source null
    related pmid
    29208381
    relationship
    Comment in
  8. citation
    Lancet Oncol. 2017 Nov;18(11):e628. doi: 10.1016/S1470-2045(17)30800-8.
    note
    Source null
    related pmid
    29208382
    relationship
    Comment in
  9. citation
    J Thorac Dis. 2017 Sep;9(9):2843-2846. doi: 10.21037/jtd.2017.08.113.
    note
    Source null
    related pmid
    29221253
    relationship
    Comment in

Authors and identifiers

  1. name
    Faivre-Finn C
    type
    Author
  2. name
    Snee M
    type
    Author
  3. name
    Ashcroft L
    type
    Author
  4. name
    Appel W
    type
    Author
  5. name
    Barlesi F
    type
    Author
  6. name
    Bhatnagar A
    type
    Author
  7. name
    Bezjak A
    type
    Author
  8. name
    Cardenal F
    type
    Author
  9. name
    Fournel P
    type
    Author
  10. name
    Harden S
    type
    Author
  11. name
    Le Pechoux C
    type
    Author
  12. name
    McMenemin R
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Faivre-Finn C
    type
    Author
  2. name
    Snee M
    type
    Author
  3. name
    Ashcroft L
    type
    Author
  4. name
    Appel W
    type
    Author
  5. name
    Barlesi F
    type
    Author
  6. name
    Bhatnagar A
    type
    Author
  7. name
    Bezjak A
    type
    Author
  8. name
    Cardenal F
    type
    Author
  9. name
    Fournel P
    type
    Author
  10. name
    Harden S
    type
    Author
  11. name
    Le Pechoux C
    type
    Author
  12. name
    McMenemin R
    type
    Author
bibliography ids
  1. nci-bib-7ca5868733a572f56ef49f6e
book metadata
content sha256
f6e35094f42e597ee3f66970b9807c0de9b6b421c9d0163b68280accaa60de16
document type
citation
dois
  1. 10.1016/S1470-2045(17)30318-2
electronic publication date
display
2017 Jun 20
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28642008
immutable id
pubmed:28642008@f6e35094f42e597ee3f66970b9807c0de9b6b421c9d0163b68280accaa60de16
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
8
name
The Lancet. Oncology
nlm unique id
100957246
pages
1116-1125
volume
18
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2017 Aug;18(8):994-995. doi: 10.1016/S1470-2045(17)30439-4.
    note
    Source null
    related pmid
    28642007
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2017 Oct;18(10):e553. doi: 10.1016/S1470-2045(17)30580-6.
    note
    Source null
    related pmid
    28971812
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2017 Oct;18(10):e554. doi: 10.1016/S1470-2045(17)30581-8.
    note
    Source null
    related pmid
    28971813
    relationship
    Comment in
  4. citation
    Lancet Oncol. 2017 Oct;18(10):e555. doi: 10.1016/S1470-2045(17)30620-4.
    note
    Source null
    related pmid
    28971814
    relationship
    Comment in
  5. citation
    Lancet Oncol. 2017 Oct;18(10):e556. doi: 10.1016/S1470-2045(17)30611-3.
    note
    Source null
    related pmid
    28971815
    relationship
    Comment in
  6. citation
    Strahlenther Onkol. 2018 Jan;194(1):73-75. doi: 10.1007/s00066-017-1234-6.
    note
    Source null
    related pmid
    29143097
    relationship
    Comment in
  7. citation
    Lancet Oncol. 2017 Nov;18(11):e627. doi: 10.1016/S1470-2045(17)30808-2.
    note
    Source null
    related pmid
    29208381
    relationship
    Comment in
  8. citation
    Lancet Oncol. 2017 Nov;18(11):e628. doi: 10.1016/S1470-2045(17)30800-8.
    note
    Source null
    related pmid
    29208382
    relationship
    Comment in
  9. citation
    J Thorac Dis. 2017 Sep;9(9):2843-2846. doi: 10.21037/jtd.2017.08.113.
    note
    Source null
    related pmid
    29221253
    relationship
    Comment in
outcomes validated
false
pmid
28642008
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
c3b8b25c728cbfc8cc43d4ea9aad72a6dfa35bb382afc7d87fa3b3633642b8ef
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Aug
precision
month
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28642008/
title
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial.

Preserved source evidence · Not medical advice